BRPI0818718A2 - Processo de preparo de uma composição de vacina compreendendo pelo menos um antígeno e pelo menos um adjuvante - Google Patents

Processo de preparo de uma composição de vacina compreendendo pelo menos um antígeno e pelo menos um adjuvante

Info

Publication number
BRPI0818718A2
BRPI0818718A2 BRPI0818718A BRPI0818718A2 BR PI0818718 A2 BRPI0818718 A2 BR PI0818718A2 BR PI0818718 A BRPI0818718 A BR PI0818718A BR PI0818718 A2 BRPI0818718 A2 BR PI0818718A2
Authority
BR
Brazil
Prior art keywords
adjuvant
antigen
preparing
vaccine composition
vaccine
Prior art date
Application number
Other languages
English (en)
Inventor
Laurent Dupuis
Jérôme Gaucheron
Olivier Braun
Original Assignee
Seppic Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seppic Sa filed Critical Seppic Sa
Publication of BRPI0818718A2 publication Critical patent/BRPI0818718A2/pt
Publication of BRPI0818718B1 publication Critical patent/BRPI0818718B1/pt
Publication of BRPI0818718B8 publication Critical patent/BRPI0818718B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
BRPI0818718A 2007-10-24 2008-10-06 processo de preparo de uma composição de vacina compreendendo antígeno e adjuvante na forma de látex inverso de homopolímero do ácido acrílico BRPI0818718B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0758542A FR2922767B1 (fr) 2007-10-24 2007-10-24 Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.
PCT/FR2008/051807 WO2009053601A2 (fr) 2007-10-24 2008-10-06 Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant

Publications (3)

Publication Number Publication Date
BRPI0818718A2 true BRPI0818718A2 (pt) 2015-04-22
BRPI0818718B1 BRPI0818718B1 (pt) 2019-08-27
BRPI0818718B8 BRPI0818718B8 (pt) 2021-05-25

Family

ID=39496110

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818718A BRPI0818718B8 (pt) 2007-10-24 2008-10-06 processo de preparo de uma composição de vacina compreendendo antígeno e adjuvante na forma de látex inverso de homopolímero do ácido acrílico

Country Status (9)

Country Link
US (1) US9795565B2 (pt)
EP (1) EP2211834A2 (pt)
JP (1) JP5710260B2 (pt)
CN (1) CN101808619B (pt)
AR (1) AR069010A1 (pt)
BR (1) BRPI0818718B8 (pt)
FR (1) FR2922767B1 (pt)
RU (1) RU2500421C2 (pt)
WO (1) WO2009053601A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2957933B1 (fr) * 2010-03-24 2012-04-27 Seppic Sa Vaccin vivant pour maladies aviaires
MX352641B (es) * 2010-07-08 2017-12-01 United Biomedical Inc Vacuna contra pcv2 basada en peptidos de diseño.
FR3026012B1 (fr) * 2014-09-23 2017-12-01 Soc D'exploitation De Produits Pour Les Industries Chimiques Seppic Administration par voie orale d'au moins une substance active pharmaceutique et/ou antigenique
MX2021010105A (es) * 2016-06-01 2022-06-16 Infectious Disease Res Inst Particulas de nanoalumbre que contienen un agente de dimensionamiento.
FR3092754B1 (fr) 2019-02-18 2022-06-03 Total Marketing Services Composition adjuvante pour vaccin
CN111658780B (zh) * 2019-10-14 2021-10-12 四川大学 一种基于阴离子聚合物及其衍生物制备的疫苗载体
FR3107454B1 (fr) 2020-02-20 2023-02-10 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Adjuvant de vaccin comprenant un microlatex inverse
RU2741834C1 (ru) * 2020-07-17 2021-01-29 Муса Тажудинович Абидов Вакцина и способ повышения иммуногенности и специфической активности средств профилактики инфекций

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
EP0301532A3 (en) 1987-07-30 1989-10-18 The B.F. Goodrich Company Solvent free acrylic acid type thickening agents and a method of making same
MX18621A (es) * 1988-12-19 1993-11-01 American Cyanamid Co Polimero en microparticulas soluble en agua, proceso para la preparacion del polimero, metodo para concentrar dispersion de solidos suspendidos y papel con resistencia para aplicaciones en seco y/o humedo
FR2649013B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
US5288814A (en) * 1992-08-26 1994-02-22 The B. F. Goodrich Company Easy to disperse polycarboxylic acid thickeners
FR2700957B1 (fr) 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
FR2717694B1 (fr) * 1994-03-22 1996-05-03 Seppic Sa Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.
JP4104186B2 (ja) * 1995-11-30 2008-06-18 財団法人化学及血清療法研究所 オイルアジュバントワクチンおよびその調製方法
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
FR2767327B1 (fr) * 1997-08-14 1999-10-29 Atochem Elf Sa Nouveaux polymeres associatifs et leur procede de preparation par emulsion inverse
JPH11106351A (ja) * 1997-10-02 1999-04-20 Chemo Sero Therapeut Res Inst オイルアジュバントワクチンおよびその製造方法
NZ503636A (en) 1997-10-17 2002-05-31 Fort Dodge Australia Pty Vaccines for the prevention of clostridial diseases of sheep that provide effective immunity for up to a year or more from a single dose
JP2001151699A (ja) * 1999-11-29 2001-06-05 Nippon Surfactant Kogyo Kk 動物用ワクチンのオイルアジュバント
US6551598B2 (en) * 2000-01-21 2003-04-22 Merial Vaccination against canine herpesvirosis and vaccines therefor
US6605674B1 (en) * 2000-06-29 2003-08-12 Ondeo Nalco Company Structurally-modified polymer flocculants
US6676958B2 (en) * 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
FR2856691B1 (fr) * 2003-06-26 2005-08-26 Seppic Sa Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant
US20050048016A1 (en) * 2003-07-02 2005-03-03 L'oreal Composition containing a silicone elastomer and a block silicone copolymer

Also Published As

Publication number Publication date
AR069010A1 (es) 2009-12-23
WO2009053601A3 (fr) 2009-06-25
RU2010119456A (ru) 2011-11-27
CN101808619A (zh) 2010-08-18
FR2922767B1 (fr) 2009-12-18
JP2011500772A (ja) 2011-01-06
WO2009053601A2 (fr) 2009-04-30
BRPI0818718B8 (pt) 2021-05-25
US9795565B2 (en) 2017-10-24
US20100233196A1 (en) 2010-09-16
FR2922767A1 (fr) 2009-05-01
EP2211834A2 (fr) 2010-08-04
CN101808619B (zh) 2011-11-30
RU2500421C2 (ru) 2013-12-10
BRPI0818718B1 (pt) 2019-08-27
JP5710260B2 (ja) 2015-04-30

Similar Documents

Publication Publication Date Title
FR22C1008I2 (fr) Composition immunogène
BRPI0818718A2 (pt) Processo de preparo de uma composição de vacina compreendendo pelo menos um antígeno e pelo menos um adjuvante
FR21C1002I1 (fr) Vaccin pour la protection contre lawsonia intracellularis
BRPI0814611A2 (pt) Composição, processo para preparar uma composição, e, uso de uma composição
BRPI0813307A2 (pt) Composição imunogênica, vacina, e, processo para fabricar a vacina
BRPI0814594A2 (pt) Composições e métodos adjuvantes de antígeno
ATE516817T1 (de) Impfstoffe zur immunisierung gegen helicobacter
BRPI0809600A2 (pt) vírus atenuado útil para vacinas
DE602007003596D1 (de) Impfstoff
BRPI0813892A2 (pt) composições que compreendem antígenos pneumococcal
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0908394A2 (pt) Composição polimerizável para material ótico, material ótico e processo para produção de material ótico
EP2351581A4 (en) VACCINE COMPOSITION AGAINST MALE AND CLAUSE DISEASE AND PREPARATION METHOD THEREFOR
BRPI1012890A2 (pt) composição adjuvante aquosa, composição imunogênica, processo para preparar uma composição imunogênica, e, kit
DK2114993T3 (da) Vaccine
CR10571A (es) Vacuna virica recombinante
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI0812422A2 (pt) Processo de preparação de um aldeído hidroxiaromático
BRPI0905847A2 (pt) "composição farmacêutica injetável e processo para preparar a composição"
BRPI0815602A2 (pt) Composições de liberação prolongada de trimetazidina e processo para a preparação das mesmas
BRPI0810865A2 (pt) antígenos de tripanossoma, composições vacinais, e métodos relacionados
DK2402032T3 (da) Immunogen sammensætning
BRPI0918487A2 (pt) processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero
BRPI0812089A2 (pt) Processo para preparação de um alquileno glicol
BRPI1016109A2 (pt) "composto, composição farmacêutica, e, processo para preparar um composto"

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/08/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/08/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF